| Code |
| PRDA |
| Title |
| PT Prodia Widyahusada Tbk |
| Address |
|
| Background |
Currently, the Company's principal activity is to provide health check up. |
| Business cp product |
Currently, the Company's principal activity is to provide health check up. |
| Subsidiary affiliation |
| Subsidiaries | Domicile | Business | % | | PT Prodia OHI International | Jakarta | Health services | 40 | | PT Prodia Stemcell Indonesia | Jakarta | Health support services | 95 | | PT Prodia Diagnostic Line | Cikarang | Trade and industry | 80 | | PT Innovasi Diagnostika | Jakarta | Health services | 52 |
|
| Commissioners |
| President Commissioner | : Drs. Andi Widjaja, MBA | | | Commissioner | : Drs. Gunawan Prawiro Soeharto | | | Commissioner | : Dra. Endang Wahjuningtyas Hoyaranda | | | Independent Commissioner | : Joseph Fellipus Peter Luhukay | | | Independent Commissioner | : Keri Lestari Dandan | | | | | | Per 30 Sep 2023 | | |
|
| Directors |
| President Director | : Dr. Dewi Muliaty, M.Si | | | Director | : Liana Kuswandi, SE,M.Fin | | | Director | : Andri Hidayat, M.Si | | | Director | : Dr. Indriyanti Rafi Sukmawati, M.Si | | | Director | : Ida Zuraida | | | | | | Per 30 Sep 2023 | | |
|
| Underwriter |
| PT. Citigroup Securities Indonesia | | | PT. Credit Suisse Securities Indonesia | | | PT Indo Premier Securities | |
| Share registrar |
|
| Share holders |
| Shareholders | Shares | % | | | | PT Prodia Utama | 534375000 | 57 | | | | Bio Majesty Pte.Ltd. | 140625000 | 15 | | | | Ida Zuraida | 400 | 0 | | | | Public | 262499600 | 28 | | | | | | | | | As of Sep 30, 2023 | | | | |
|
| History stocks |
Type of ListingDatePrice## of SharesTotal Listed Shares IPO @ Rp 650007-Dec-2016100187500000937500000
|
| Other infos |
|
| Created date |
| 2023-11-03 14:32:31 |
| Revised date |
| 2023-11-03 14:32:31 |
| Finance |
| PT Prodia Widyahusada Tbk |
2023,
2022,
2021,
2020,
2019,
2018,
2017,
2016,
2015,
2014,
2013,
| Financial Statetment Date |
| Fiscal Year Ends |
| Months Covered in Income St |
| |
| Summary Covered in Income St |
| Cash and Cash Equivalents |
| Receivables |
| Inventories |
| Current Assets |
| Fixed Assets |
| Other Assets |
| Non Current Assets |
| Total Assets |
| Current Liabilities |
| Longterm Liabilities |
| Total Liabilities |
| Authorized |
| Paid-up Capital |
| Par Value |
| Paid-up Capital Shares |
| Retained Earnings |
| Total Equity |
| Minority Interest |
| |
| Summary of Income Statement |
| Total Sales |
| Cost of Good Sold |
| Gross Profit |
| Operating Profit |
| Other Income |
| Earning Before Tax |
| Tax |
| Net Income |
| Close Price |
| |
| Per Share Data (Rp) |
| Eps (annualized) |
| Book Value |
| |
| Financial Ratios |
| Debt Equity Ratio (X) |
| Roa(%) |
| Roe(%) |
| Npm(%) |
| Opm(%) |
| Gross Profit Margin (%) |
| Total Assets Turnover |
| |
| Cash Flow |
| CF from Operation Activities |
| CF from Investing Activities |
| CF from Financing Activities |
| Net Increase in Cash & Cash Equivalent |
| Cash & Cash Equivalent at Beginning of the Year |
| Cash & Cash Equivalent at The End of the Year |
|
|